The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells

…, JL Meade, TD Holmes, D McGonagle, SL Mackie… - Cancer research, 2007 - AACR
Recent evidence suggests a role for natural killer (NK) cells in the control of multiple myeloma.
We show that expression of the NK cell receptor DNAM-1 (CD226) is reduced on CD56 …

British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis

SL Mackie, C Dejaco, S Appenzeller… - …, 2020 - academic.oup.com
Background GCA is a large vessel vasculitis affecting older people, with the highest incidence
among persons 70–79 years of age [1]. Due to forecasted demographic changes, it has …

[PDF][PDF] A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility

FD Carmona, SL Mackie, JE Martín, JC Taylor… - The American Journal of …, 2015 - cell.com
We conducted a large-scale genetic analysis on giant cell arteritis (GCA), a polygenic
immune-mediated vasculitis. A case-control cohort, comprising 1,651 case subjects with GCA and …

Diagnostic accuracy of symptoms, physical signs, and laboratory tests for giant cell arteritis: a systematic review and meta-analysis

…, M Sandovici, E Brouwer, SL Mackie - JAMA internal …, 2020 - jamanetwork.com
Importance Current clinical guidelines recommend selecting diagnostic tests for giant cell
arteritis (GCA) based on pretest probability that the disease is present, but how pretest …

[HTML][HTML] Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician …

…, C Hill, D Liew, SL Mackie, P Mehta, L Neill… - The Lancet …, 2021 - thelancet.com
Background Patients with primary systemic vasculitis or polymyalgia rheumatica might be at
a high risk for poor COVID-19 outcomes due to the treatments used, the potential organ …

[HTML][HTML] Diagnostic delay for giant cell arteritis–a systematic review and meta-analysis

JA Prior, H Ranjbar, J Belcher, SL Mackie, T Helliwell… - BMC medicine, 2017 - Springer
Background Giant cell arteritis (GCA), if untreated, can lead to blindness and stroke. The
study’s objectives were to (1) determine a new evidence-based benchmark of the extent of …

[PDF][PDF] A genome-wide association study identifies risk alleles in plasminogen and P4HA2 associated with giant cell arteritis

FD Carmona, A Vaglio, SL Mackie… - The American Journal of …, 2017 - cell.com
Giant cell arteritis (GCA) is the most common form of vasculitis in individuals older than 50
years in Western countries. To shed light onto the genetic background influencing …

[HTML][HTML] Description and validation of histological patterns and proposal of a dynamic model of inflammatory infiltration in giant-cell arteritis

…, G Murgia, I Villar, E Campo, SL Mackie… - Medicine, 2016 - journals.lww.com
The extent of inflammatory infiltrates in arteries from patients with giant-cell arteritis (GCA)
have been described using different terms and definitions. Studies investigating the …

Can the prognosis of polymyalgia rheumatica be predicted at disease onset? Results from a 5-year prospective study

SL Mackie, EMA Hensor, G Haugeberg… - …, 2010 - academic.oup.com
Objective. To identify the features of PMR that may predict the duration of steroid therapy,
the occurrence of relapses and the late development of GCA. Methods. Prospective cohort …

[PDF][PDF] A probability score to aid the diagnosis of suspected giant cell arteritis

F Laskou, F Coath, SL Mackie, S Banerjee… - Clin Exp …, 2019 - clinexprheumatol.org
Objective. We propose a GCA probability score intended to help to riskstratify patients
referred by general practitioners with suspected GCA into those with high probability of GCA …